1. Home
  2. HCM vs HBI Comparison

HCM vs HBI Comparison

Compare HCM & HBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • HBI
  • Stock Information
  • Founded
  • HCM 2000
  • HBI 1901
  • Country
  • HCM Hong Kong
  • HBI United States
  • Employees
  • HCM N/A
  • HBI N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • HBI Clothing/Shoe/Accessory Stores
  • Sector
  • HCM Health Care
  • HBI Consumer Discretionary
  • Exchange
  • HCM Nasdaq
  • HBI Nasdaq
  • Market Cap
  • HCM 2.6B
  • HBI 2.1B
  • IPO Year
  • HCM N/A
  • HBI 2006
  • Fundamental
  • Price
  • HCM $14.98
  • HBI $5.79
  • Analyst Decision
  • HCM Hold
  • HBI Hold
  • Analyst Count
  • HCM 1
  • HBI 5
  • Target Price
  • HCM $19.00
  • HBI $7.10
  • AVG Volume (30 Days)
  • HCM 85.0K
  • HBI 7.7M
  • Earning Date
  • HCM 03-19-2025
  • HBI 05-08-2025
  • Dividend Yield
  • HCM N/A
  • HBI N/A
  • EPS Growth
  • HCM N/A
  • HBI N/A
  • EPS
  • HCM 0.04
  • HBI N/A
  • Revenue
  • HCM $630,201,000.00
  • HBI $3,507,438,000.00
  • Revenue This Year
  • HCM $28.98
  • HBI $0.79
  • Revenue Next Year
  • HCM $20.41
  • HBI $0.25
  • P/E Ratio
  • HCM $69.52
  • HBI N/A
  • Revenue Growth
  • HCM N/A
  • HBI N/A
  • 52 Week Low
  • HCM $12.84
  • HBI $4.40
  • 52 Week High
  • HCM $21.92
  • HBI $9.10
  • Technical
  • Relative Strength Index (RSI)
  • HCM 47.89
  • HBI 35.04
  • Support Level
  • HCM $14.00
  • HBI $5.78
  • Resistance Level
  • HCM $15.57
  • HBI $5.97
  • Average True Range (ATR)
  • HCM 0.47
  • HBI 0.18
  • MACD
  • HCM -0.11
  • HBI 0.05
  • Stochastic Oscillator
  • HCM 37.12
  • HBI 26.61

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About HBI Hanesbrands Inc.

Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated as it produces nearly 75% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina.

Share on Social Networks: